NCT03044106

Brief Summary

Purpose: To conduct a pilot study of the effect of Cranial Laser Reflex Technique (CLRT) compared with sham laser on hamstring muscle flexibility, strength, and pain pressure threshold. Participants: Active, young adults ages 18 to 35. Procedures: A two-visit, assessor and participant-blinded crossover study with 1-week washout. Subjects will complete three functional hamstring tests before and after CLRT and sham laser treatment. Subjects will also complete questionnaires to assess their expectations and perceptions of the interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 2, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 6, 2017

Completed
26 days until next milestone

Study Start

First participant enrolled

March 4, 2017

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2017

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

January 29, 2019

Completed
Last Updated

February 12, 2019

Status Verified

October 1, 2017

Enrollment Period

5 months

First QC Date

February 2, 2017

Results QC Date

October 3, 2018

Last Update Submit

January 28, 2019

Conditions

Keywords

hamstringsflexibilitystrengthpain pressure thresholdllltphotobiomodulationcranial reflexcranial laser reflex techniqueCLRT

Outcome Measures

Primary Outcomes (1)

  • 90-90 Knee Extension Angle Test

    Knee Extension Angle (KEA) test is a functional test designed to assess lower extremity flexibility and is considered the gold standard test for assessing hamstring length. Results will be recorded as degrees of knee flexion angle. A clinically significant effect size is an increase of 5 degrees.

    At baseline and immediately after intervention

Secondary Outcomes (3)

  • Handheld Dynamometry

    At baseline and immediately after intervention

  • Pain Pressure Threshold

    At baseline and immediately after intervention

  • Mean Difference Pre/Post KEA, Stratified by History of Prior Hamstring Strain

    At baseline and immediately after intervention

Study Arms (2)

CLRT, Then Sham

ACTIVE COMPARATOR

Subjects performed the KEA, HHD, PPT functional tests on their right hamstring before and after the CLRT intervention.

Device: CLRT

Sham, Then CLRT

SHAM COMPARATOR

The Sham procedure was identical to CLRT except the laser device was placed in placebo mode: all device indicator lights and sounds will be functional but no laser light will be emitted from probe aperture.

Device: CLRT

Interventions

CLRTDEVICE

CLRT is a novel method of laser stimulation on specific cranial reflex points that modulate muscle tone.

Also known as: Cranial Laser Reflex Technique
CLRT, Then ShamSham, Then CLRT

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Between 18-35 years of age
  • All genders
  • Willing to complete two study visits over 2-3 weeks
  • Able to read and communicate in English

You may not qualify if:

  • Current lower back condition with pain, numbness or tingling that radiates down the legs
  • Active treatment for a major medical illness, such as heart disease, uncontrolled diabetes or hypertension, malignancy, autoimmune, or immune deficiency disorder
  • History of vasculitis, intracranial mass, clotting disorder (including medication-induced, e.g., warfarin)
  • Current skin malignancy on scalp
  • Cognitive dysfunction preventing informed consent
  • Pending or currently receiving benefits from personal injury litigation, including worker's compensation
  • Chronic long-term disability related to lumbosacral injury/symptoms
  • Epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC- Chapel Hill

Chapel Hill, North Carolina, 27514, United States

Location

Related Links

MeSH Terms

Conditions

Muscle HypertoniaMyalgiaMuscle Weakness

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular DiseasesMusculoskeletal DiseasesNeuromuscular DiseasesMusculoskeletal PainPainPathologic Processes

Limitations and Caveats

The high baseline flexibility of the population may have a ceiling effect on the intervention. Further examination of the effects of CLRT in a clinical population is warranted.

Results Point of Contact

Title
Nicholas Wise, DC
Organization
University of North Carolina at Chapel Hill

Study Officials

  • Nicholas A Wise, D.C.

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Subjects and assessors were blinded to treatment allocation. The subject was face down, eyes closed, and wearing protective eyewear that blocks the specific wavelength of the laser light during the intervention. After each treatment session, the participants completed a de-blinding questionnaire administrated by the assessor providing a dichotomous 'yes' or 'no' answer as to whether active treatment was received. This response was followed by a second question regarding how certain they were that active treatment was received on a 0-10 numeric rating scale (NRS), where 0 represents absolutely uncertain and 10 represents absolutely certain.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Subjects who meet the inclusion criteria and give consent were randomized to one of the following for the first treatment period: 1) active CLRT; or 2) sham laser. At the first intervention visit, the research assistant entered the subject's assigned identification into an online computer program (selected by study biostatistician) to determine assignment to one of the two periods. The study biostatistician used computer-generated random numbers to generate the allocation sequence using random blocks of random sizes. A one-week washout period minimized carryover effects.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2017

First Posted

February 6, 2017

Study Start

March 4, 2017

Primary Completion

July 31, 2017

Study Completion

July 31, 2017

Last Updated

February 12, 2019

Results First Posted

January 29, 2019

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations